Did You Lose Money Investing in Vistagen Therapeutics, Inc.? Contact Robbins LLP for Information About Your Rights Against VTGN
SAN DIEGO, CA / ACCESS Newswire / January 22, 2026 / Robbins LLP reminds investors that a class action was filed against Vistagen Therapeutics, Inc. (NASDAQ:VTGN) Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. For more information, submit a form, email attorney Aaron […]